PheWAS results indicated that TGM2 was primarily associated with Cardiometabolic traits, suggesting that drugs targeting the TGM2 gene in ESCC may have an impact on these traits (Figures 12A, B). The gene discussed is TGM2; the disease is esophageal squamous cell carcinoma.